Plné znění - 278/2014 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2015

278/2014 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

278

XXXXXXX

Xxxxxxxxxxxx xxxxxxxxxxxxx

xx xxx 20. xxxxxxxxx 2014

x xxxxxxxxxx xxxxxxx očkovacích xxxxx pro pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx rok 2015

Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 odst. 1 xxxx. e) xxxxxx x. 258/2000 Sb., x xxxxxxx xxxxxxxxx xxxxxx a x xxxxx xxxxxxxxx souvisejících xxxxxx, xx znění xxxxxxxxxx předpisů, xxxxxxx xx xxxxxxx doporučení Xxxxxxx xxxxxxxxxx komise xxxxxxxxx složení očkovacích xxxxx pro xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx pro xxx 2015:

1. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxxx očkování

1a) kombinovaná xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx X, nákazám xxxxxxxxx Xxxxxxxxxxx influenzae xxx x (XXxXXxxXXXXXX):

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx filamentosum

Pertussis xxxxxxxxx xxxxxxxx proteinum

Diphtheriae xxxxxxxxxx

Xxxxxx xxxxxxxxxx xxx.

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B xxxxxxxxxxxxxx

Xxxxx poliomyelitidis xxxxxxxxxxx xxxxx 1

Xxxxx poliomyelitidis xxxxxxxxxxx typus 2

Xxxxx xxxxxxxxxxxxxxx inactivatum xxxxx 3

Xxxxxxxxxx Hib: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Tetani anatoxinum

NEBO

1aa) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, dětské přenosné xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx b ( XXxXXxxXXXXXX)

Xxxxxxxxxxx anatoxinum

Tetani xxxxxxxxxx

Xxxxxxxx Xxxxxxxxxx pertussis

Pertussis xxxxxxxxxx

Xxxxxxxxxxxxxx filamentosum

Virus Poliomyelitidis (xxxxxxxxxxxx)

xxxxx 1 (Mahoney)

typus 2 (MEF-1)

typus 3 (Xxxxxxx)

Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X

Xxxxxxxxxxx xxxxxxxxxx xxxx x polysaccharidum

(Polyribosylribitoli xxxxxxxx)

xxxxxxxxx xxx tetani xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx (XXxX):

Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx anatoxinum ≥ 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum filamentosum (XXX) 25 mikrogramů

Pertactinum (69xX) 8 xxxxxxxxxx

1x) xxxxxxxx látka proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Hemofilem xxxxxxxxxx x (XXxXXxx):

Xxxxxxxxxxx xxxxxxxxxx ........................................... xxx. 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx .................................................... min. 40 mezinárodních xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) ...................................... 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) .... 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) ................................................... 8 xxxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx B ....................................... 10 xxxxxxxxxx

xxx xxxxxxxxx xxxxxxxx ............................................ 20-40 xxxxxxxxxx

1x) xxxxxxxx látka xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx influenzae typ x:

1 xxxxx xxxxxxxxxxxxx xxxxxxx obsahuje: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) cum Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).

1x) xxxxxxxx xxxxx xxxxx xxxxxx:

Xxxxxx xxxxxxxxxx ................................................... min. 40 xxxxxxxxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx 15 xxx xxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X .......................... 10 xxxxxxxxxx

1x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X xx 16 let x výše:

Antigenum tegiminis xxxxxxxxxxx X ........................... 20 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:

Xxxxxxxxxxx xxxxx attenuatum (Schwarz) xxx. 10^3,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx₅₀

Xxxxxxxxxxx xxxxx xxxxxxxxxx (XXX 4385) xxx. 10^3,7 xxxxxxxx xxxxx xxx xxxxxxxx kulturu₅₀

Rubeolae xxxxx attenuatum (Xxxxxx XX 27/3) xxx. 10^3,0 infekční dávka xxx buněčnou kulturu₅₀

1ch) xxxxxxxx xxxxx xxxxx xxxxxx přenosné xxxxx x xxxxxxxxxxxx xxxxx:

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ........... 40 xxxxxxxxxxx D xxxxxxxx*

Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 2 (XXX-1) ................ 8 xxxxxxxxxxx X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) ............. 32 xxxxxxxxxxx D jednotek*

* xxxx xxxxxxxx ekvivalentních xxxxxxxx stanovené xxxxxx xxxxxx imunochemické metody.

1i) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:

Xxxxxxxxxxxxxxx Streptococci xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6B, 7X, 8, 9X, 9X, 10X, 11 X, 12F, 14, 15X, 17F, 18C, 19X, 19X, 20, 22X, 23X, 33X ...... 25 xxxxxxxxxx x xxxxxxx sérotypu

1j) xxxxxxxx látka konjugovaná xxxxx pneumokokovým infekcím:

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 3

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 14

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 23X

1xx) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxxx xxxxxxxxxx ............................... ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx ........................................ xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx anatoxinum................................... 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx filamentosum ... 8 mikrogramů

Pertaktin ...................................................... 2,5 mikrogramů

Virus xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Mahoney) .............................. 40 X xxxxxxxx xxxxxxxx

xxxxx 2 (kmen XXX-1) ................................... 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (xxxx Xxxxxxx) ................................ 32 X xxxxxxxx xxxxxxxx

XXXX

1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (acelulární xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx):

Xxxxxxxxxx xxxxxx ....................................... xxxx nebo xxxxx 2 mezinárodní xxxxxxxx (2 Xx)

Xxxxxxxxx xxxxxx ....................................... xxxx xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx toxoid ................................ 2,5 mikrogramu

Filamentózní xxxxxxxxxxxx ................. 5 mikrogramů

Fimbrie xxxx 2+3 ................................ 5 xxxxxxxxxx

Xxxxxxxxx ............................................. 3 mikrogramy

Virus poliomyelitis xxxx 1 (inaktivovaný) ... 40 xxxxxxxxxxx X xxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) ... 8 xxxxxxxxxxx X xxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) ... 32 antigenních X xxxxxxxx

1x) očkovací xxxxx xxxxx tuberkulóze:

Mycobacterium xxxxx xxxxxxxxxx (XXX) xxxxxxx Xxxxxxx 1331 ... 0,75 mg ≥ 2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xxx osoby xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx AS04C xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx x 1 dávce

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxx xxxxxxxx

2x) xxxxxxxx látka xxxxx xxxxxx hepatitidě X xx formuli xxx dospělé:

Antigenum tegiminis xxxxxxxxxxx X 20 xxxxxxxxxx

2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx

Xxxxx rabiei xxxxxxxxxxx (xxxx Wistar xxxxxx PM/WI 38&xxxx;1503-3X xxxx xxxx rovno 2,5 mezinárodních xxxxxxxx x 1 xxxxx (0,5 xx)

2x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx pro dospělé:

Hepatitis X virus xxxxxxxxxxx

3. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx mimořádná xxxxxxxx

3x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:

Xxxxxxxxx X xxxxx xxxxxxxxxxx

3x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx A ve xxxxxxx xxx xxxx:

Xxxxx xxxxxxxxx A inactivatum

V xxxx 2015 x xxxxxxx na xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x očkování proti xxxxxxxxx nemocem, nelze xxxxxxxx xxxxxxxxx xxxxxx xxxxxxxxxxx složení očkovacích xxxxx xxx xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx látek xx Xxxxxx xxxxxx.

Xxxxxxx:

XXXx. Xxxxxxx, XXX, x. x.

Xxxxxxxxx

Xxxxxx xxxxxxx x. 278/2014 Xx. nabyl xxxxxxxxx dnem 13.12.2014.

Xx xxx xxxxxxxx xxxxxx xxxxxxx nebyl xxxxx xx xxxxxxxxx.

Xxxxx jednotlivých xxxxxxxx norem jiných xxxxxxxx xxxxxxxx v xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.